Market revenue in 2022 | USD 1,076.4 million |
Market revenue in 2030 | USD 2,564.8 million |
Growth rate | 11.5% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.6% in 2022. Horizon Databook has segmented the Canada molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
Growing investments in research projects and increasing awareness about genomics in the country are factors contributing to the market growth in Canada.
For instance, in April 2020, Genome Canada launched Canadian COVID Genomics Network (CanCOGeN) initiative to scale-up genomics-based COVID19 research in the country. This initiative is backed up by federal funding of USD 40 million.
Furthermore, in July 2019, the Government of Canada invested USD 41.2 million to support 19 genomics research projects. This investment supported development of research collaborations and innovative solutions through genomic research.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into Canada molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account